Core C: Computational Chemical Biology
Core C: Computational Chemical Biology
批准号:
8812375
负责人:
THOMAS EDWARD PRISINZANO
金额:
$22.27万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-15 至 2021-04-30
关键词:
AddressBindingBiochemicalBiologicalBiological AssayBiologyCell Membrane PermeabilityCenters of Research ExcellenceCharacteristicsChemical StructureChemicalsCommunicable DiseasesCommunitiesComplementComputational TechniqueComputer SimulationDataData AnalysesData Base ManagementDatabasesDockingDrug KineticsExcretory functionGoalsIn VitroIndiumInformation ManagementKansasLeadLigand BindingLigandsMetabolismMethodsModelingMolecular ConformationPharmaceutical ChemistryPositioning AttributePropertyProtein FamilyProteinsReportingResearchResearch InfrastructureResearch PersonnelResearch SupportRoleScientistServicesSolubilitySorting - Cell MovementStructureStructure-Activity RelationshipToxic effectValidationWorkabsorptionanalogassay developmentbasebiological researchcheminformaticscomputer infrastructuredata structuredesignhigh throughput screeningindexinginterestoutreachpharmacophorephysical propertyprogramsscreeningvirtual
中文摘要
总结
英文摘要
SUMMARY
Computational Chemical Biology (CCB) Core will provide comprehensive computational support, including
chemical virtual screening, physical property prediction, target validation, hits identification, lead
optimization, pharmacophore identification, and pharmacokinetic and dynamic modeling. In addition, the CCB
core will provide information management infrastructure supporting the creation and management of scientific
data analysis workflows, project reporting, and database management for chemicals including their structures
and biological properties. These activities will be fully integrated with projects and with Cores B and D. For
example, the analysis of high-throughput screening data and chemical structure-activity relationship data
generated by Core B will be stored, indexed, computationally analyzed, and visualized at the CCB Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Agents for Synthetic Opioid Overdose
-
批准号:10275603
-
项目类别:
-
资助金额:$45.9万
-
财政年份:2021
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Development of Agents for Synthetic Opioid Overdose
-
批准号:10672919
-
项目类别:
-
资助金额:$44.42万
-
财政年份:2021
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Development of Agents for Synthetic Opioid Overdose
-
批准号:10470923
-
项目类别:
-
资助金额:$45.01万
-
财政年份:2021
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Chemical Biology of Infectious Disease
-
批准号:9274106
-
项目类别:
-
资助金额:$226.53万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Alteration and Renovation
-
批准号:8812380
-
项目类别:
-
资助金额:$9.28万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:9030515
-
项目类别:
-
资助金额:$48.75万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Administrative Core
-
批准号:8812373
-
项目类别:
-
资助金额:$98.92万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Chemical Biology of Infectious Disease
-
批准号:8812366
-
项目类别:
-
资助金额:$236.42万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:9266380
-
项目类别:
-
资助金额:$43.69万
-
财政年份:2016
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Legacy continuation of the KU CMLD Mission
-
批准号:8753214
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2014
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7033693
-
项目类别:
-
资助金额:$34.25万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8523815
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8472068
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8035337
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7424261
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8702125
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:8306178
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7266507
-
项目类别:
-
资助金额:$3.74万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7127177
-
项目类别:
-
资助金额:$32.29万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
Investigation of Neoclerodanes as Novel Opioid Ligands
-
批准号:7493038
-
项目类别:
-
资助金额:$31.78万
-
财政年份:2005
-
负责人:THOMAS EDWARD PRISINZANO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: